Levels of FGL-1 are higher in overweight and obese subjects, and are positively correlated with BMI, waist circumference, degree of obesity, and insulin resistance, suggesting thatFGL-1 may link obesity, diabetes and NAFLD (27). The gene discussed is FGL1; the disease is metabolic dysfunction-associated steatotic liver disease.